BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8011538)

  • 21. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
    Smith MA; Rubinstein L; Ungerleider RS
    Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.
    Scholl C; Schlenk RF; Eiwen K; Döhner H; Fröhling S; Döhner K;
    Haematologica; 2005 Dec; 90(12):1626-34. PubMed ID: 16330435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cytogenetics reveals complex karyotype in apparent t(8;13) therapy-related acute myeloid leukemia M2 after fibrosarcoma.
    Soares-Ventura EM; Mkrtchyan H; de Jesus Marques-Salles T; Silva M; Santos N; de Araujo Silva Amaral B; Liehr T; Abdelhay E; Silva ML; Muniz MT
    Leuk Res; 2011 May; 35(5):e27-9. PubMed ID: 21329977
    [No Abstract]   [Full Text] [Related]  

  • 24. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
    Brown SA; Czepulkowski B; Ireland R
    Leuk Res; 1996; 20(11-12):987-8. PubMed ID: 9009258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
    Innes A; May PC; Pavlů J; Bain BJ
    Am J Hematol; 2012 Apr; 87(4):412. PubMed ID: 21953481
    [No Abstract]   [Full Text] [Related]  

  • 26. Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.
    Silva ML; Land MG; Maradei S; Otero L; Veith M; Brito G; Klumb C; Fernandez T; Pombo-de-Oliveira MS
    Cancer Genet Cytogenet; 2002 May; 135(1):101-2. PubMed ID: 12072208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses.
    Nawata R; Shinohara K; Yamada T; Takahashi T; Katsuki K; Takeda K; Kameda N; Ariyoshi K; Ota I; Muraki K
    Int J Hematol; 2000 Jun; 71(4):353-8. PubMed ID: 10905055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
    Colović M; Suvajdžić N; Janković G; Tomin D; Colović N; Fekete MD; Palibrk V
    Biomed Pharmacother; 2011 Aug; 65(5):319-21. PubMed ID: 21775097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translocation t(9;11)(p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia.
    Sandoval C; Head DR; Mirro J; Behm FG; Ayers GD; Raimondi SC
    Leukemia; 1992 Jun; 6(6):513-9. PubMed ID: 1602790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML.
    Kajita N; Saito Y; Makimoto A; Miyahara S; Yuza Y
    Pediatr Int; 2020 Jun; 62(6):742-744. PubMed ID: 32495974
    [No Abstract]   [Full Text] [Related]  

  • 31. [A case of secondary leukemia in anaplastic seminoma patient treated with long-term chemotherapy].
    Kamai T; Touma T; Masuda H; Hyouchi N; Okuno T; Yonese J; Fukuda H; Tachibana Y; Ishiwata D
    Nihon Hinyokika Gakkai Zasshi; 1996 May; 87(5):875-9. PubMed ID: 8691713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy.
    Linassier C; Barin C; Calais G; Letortorec S; Brémond JL; Delain M; Petit A; Georget MT; Cartron G; Raban N; Benboubker L; Leloup R; Binet C; Lamagnère JP; Colombat P
    Ann Oncol; 2000 Oct; 11(10):1289-94. PubMed ID: 11106118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
    Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy-related acute myeloid leukemia with t(9;11)(p12;q23) in a patient treated for acute promyelocytic leukemia.
    Annunziata M; Palmieri S; Pocali B; De Simone M; Del Vecchio L; Vicari L; Pane F; Ferrara F
    Hematol J; 2003; 4(4):289-91. PubMed ID: 12872155
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute lymphoblastic leukaemia following Hodgkin's disease is associated with a good prognosis.
    Narayanan MN; Morgenstern GR; Chang JC; Harrison CJ; Ranson M; Scarffe JH
    Br J Haematol; 1994 Apr; 86(4):867-9. PubMed ID: 7918085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.
    Roulston D; Anastasi J; Rudinsky R; Nucifora G; Zeleznik-Le N; Rowley JD; McGavran L; Tsuchida M; Hayashi Y
    Blood; 1995 Nov; 86(9):3613-4. PubMed ID: 7579475
    [No Abstract]   [Full Text] [Related]  

  • 37. Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.
    Owatari S; Otsuka M; Uozumi K; Takeshita T; Hanada S
    Int J Hematol; 2007 Jan; 85(1):32-5. PubMed ID: 17261499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of therapy-related acute myeloblastic leukemia with t(16;21)(q24;q22) after chemotherapy with DNA-topoisomerase II inhibitors, etoposide and mitoxantrone, and the alkylating agent, cyclophosphamide.
    Takeda K; Shinohara K; Kameda N; Ariyoshi K
    Int J Hematol; 1998 Feb; 67(2):179-86. PubMed ID: 9631585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
    Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
    Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
    Yamamoto K; Nagata K; Morita Y; Hamaguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.